SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form S-8 - Securities to be offered to employees in employee benefit plans:
SEC Accession No. 0001104659-17-053442
Filing Date
2017-08-24
Accepted
2017-08-24 16:22:22
Documents
5
Effectiveness Date
2017-08-24

Document Format Files

Seq Description Document Type Size
1 S-8 a17-20703_1s8.htm S-8 132400
2 EX-5.1 a17-20703_1ex5d1.htm EX-5.1 8655
3 EX-23.1 a17-20703_1ex23d1.htm EX-23.1 3680
4 GRAPHIC g207031lsi001.jpg GRAPHIC 2336
5 GRAPHIC g207031kii001.jpg GRAPHIC 2434
  Complete submission text file 0001104659-17-053442.txt   152592
Mailing Address SUITE 400, 101 LINDENWOOD DRIVE MALVERN PA 19355
Business Address SUITE 400, 101 LINDENWOOD DRIVE MALVERN PA 19355 484-321-5554
Aclaris Therapeutics, Inc. (Filer) CIK: 0001557746 (see all company filings)

IRS No.: 460571712 | State of Incorp.: DE | Fiscal Year End: 1231
Type: S-8 | Act: 33 | File No.: 333-220149 | Film No.: 171049591
SIC: 2834 Pharmaceutical Preparations